Penn Center for Innovation

Robot dogs join US Air Force exercise giving glimpse at potential battlefield of the future

Posted on September 9, 2020 — Jessica Jones Gupta

Emerging from United States Air Force planes, four-legged robot dogs scampered onto an airfield in the Mojave Desert, offering a possible preview into the future of warfare.  The dogs are called Vision 60 UGVs, or “autonomous unmanned ground vehicles” by their manufacturer, Ghost Robotics of Philadelphia. Read More on CNN.com

Engineers develop laser-controlled, cell-sized robots

Posted on September 4, 2020 — Jessica Jones Gupta

Researchers from Penn Engineering and Cornell are looking through this lens at an even more fundamental level: creating robotic systems that are on the scale of biological cells. One of the researchers’ robots next to a paramecium. (Image: Penn Engineering) They have created the first microscopic robots that are made with semiconductor processing and can…

Fierce BioTech ranks Penn #8 on the global R&D Institute list

Posted on September 2, 2020 — Jessica Jones Gupta

Many new drugs and diagnostics would never have seen the light of day if it wasn’t for these institutes, and our top 10 are the most prolific when it comes to collabs and research pacts with the life sciences industry, with many big-name scientists and alumni working at biotech spin outs from our leading institutes….

Philadelphia-area companies, researchers battling Covid-19 among recipients of $10 million in grants

Posted on August 28, 2020 — Jessica Jones Gupta

The state will provide $10 million in grants to 23 Pennsylvania life sciences companies, universities and research institutions working on Covid-19 vaccines and treatments. The University of Pennsylvania received two grants totaling nearly $876,000 for work on a Covid-19 vaccine and on therapeutics including a study looking approaches for treating obese patients infected by the…

Penn stikes deal with Hemogenyx for sponsored research on CAR-T leukemia treatment

Posted on August 19, 2020 — Jessica Jones Gupta

Hemogenyx Pharmaceuticals plc, a biopharma company group developing new therapies for blood diseases, has entered into a sponsored research agreement with the University of Pennsylvania to advance the CAR- T cells developed by the company (HEMO-CAR-T) toward clinical trials. The research is viewed as the first step of a larger program that hopes to achieve…

2021 Penn Nursing Innovation Accelerator

Posted on August 17, 2020 — Jessica Jones Gupta

The Penn Nursing Innovation Accelerator provides up to $10k for research and development of a proposed innovation idea that has an existing low-fidelity prototype which has been minimally tested. The award amount will be determined by the budget and justification provided by the applicant (maximum of $10k). Mentorship & coaching will be provided by Penn…

New funding supports milestone initiative to advance solar energy research

Posted on August 10, 2020 — Jessica Jones Gupta

Penn’s Vagelos Institute for Energy Science and Technology is a partner in a $40 million award from the Department of Energy that will accelerate fundamental research on solar technology. Read more on Penn Today

Penn-affiliated companies included in the list of PACT Enterprise Award Finalists

Posted on August 5, 2020 — Jessica Jones Gupta

The Philadelphia Alliance for Capital and Technologies (PACT) has announced the finalists for their annual awards.  The list of finalists include four companies affiliated with Penn and the Pennovation Center (the companies are highlighted below in purple). Register for the award ceremony here.   2020 PACT Enterprise Awards Finalists Healthcare Innovator Quantitative Radiology Solutions Spirovant…

Watch the Life Science PA Annual Award Presentation

Posted on August 3, 2020 — Jessica Jones Gupta

Due to the ongoing public health crisis, Life Science PA had to convert their annual awards dinner into a virtual celebration.  The video below features several Penn spinouts and partners including: Scientific Achievement Award: Dr. Jean Bennett, a professor of ophthalmology at the University of Pennsylvania Perelman School of Medicine. Bennett’s lab developed the gene therapy treatment for…

CARISMA Therapeutics announces FDA Clearance of IND Application for first-ever engineered Macrophage Immunotherapy

Posted on July 28, 2020 — Jessica Jones Gupta

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for the Company’s lead product candidate, CT-0508, an anti-human epidermal growth factor receptor 2 (HER2) targeted chimeric antigen receptor macrophage (CAR-M). Under this IND, CARISMA…